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ABSTRACT 
Background: Patients with polycystic ovarian syndrome (PCOS) often suffer from psychiatric co-morbidities, such as 
anxiety and depression. The prevalence of PCOS is increasing In India. 
Objective: To Study anxiety and depression among PCOS Patients. 
Materials and Methods: It was a cross-sectional observational study, which was conducted in Obstetrics and 
Gynaecology department of a tertiary care hospital. Patients diagnosed with PCOS were assessed on hospital anxiety 
depression scale and sociodemographic and clinical information was gathered using semi-structured questionnaire.  
Result: The prevalence of anxiety of 36% and depression 16% were observed. 
Discussion: PCOS patients were found to have high prevalence of anxiety and depression due to the Symptoms of 
PCOS. 
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INTRODUCTION 
Polycystic ovary syndrome (PCOS) is the most 
common endocrine disorder among women of 
reproductive age, affecting approximately 5% to 10% 
of women in the Western world 
1,2
. Women with PCOS 
exhibit a wide range of symptoms presenting in varying 
combinations. These include amenorrhea, 
oligomenorrhea, menorrhea, hirsutism, subfertility or 
infertility, anovulation, weight gain or obesity, acne 
vulgaris, androgenic alopecia, excess androgen 
production, and insulin resistance
3,4 
Recently, in a 
systematic review and meta-analysis, found  that 
women with PCOS had a fourfold greater odds of 
depressive symptoms compared with age-matched 
control women
5
. Further sub analysis of body mass 
index (BMI)–matched subjects also demonstrated 
greater odds of depressive symptoms in women with 
PCOS and risk of depression in PCOS and found a 
persistent high prevalence of depression after 12–18 
months
6
. Mood disorders are commonly associated 
with anxiety disorders, especially generalized anxiety 
disorder (GAD) 
7
. The estimated prevalence of anxiety 
disorders is 5%–8% in women seen in the primary care 
setting.. Abnormal or inappropriate anxiety can become 
a problem when it occurs without any recognizable 
stimulus or when the stimulus does not warrant such a 
reaction. Often, anxiety gets generalized to other 
situations, and can then become overwhelming or 
associated with life in general. In the National 
Comorbidity Survey, patients with GAD had a high 
prevalence of social phobia, specific phobia, panic 
disorder, and major depression
8, 9
. The majority of 
people with GAD reported substantial interference with 
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their life, a high degree of professional help seeking, 
and a high use of medication to relieve their symptoms. 
There is paucity of Indian research assessing 
prevalence of anxiety and depression in PCOS. 
MATERIALS AND METHODS 
 This cross-sectional study was conducted for a period 
of 6 month from January to June 2018 among 100 
patients of PCOS from the Department of 
Gynaecology, Vinayaka Missions Kirupanada variyer 
Medical College, Salem ,India. Patients who had 
confirmed diagnosis of PCOS were explained details of 
the study and were invited to participate. The data from 
case records of the patients who diagnosed with PCOD 
during the study period were included for the study 
based on inclusion and exclusion criteria. The data 
from the case records of patients above the age of 12 
till 35 years were included for the study. All women 
provided informed consent to participate in the study. 
Only the women aged 12- 35 years were included for 
analysis to reduce any potential confounding effects of 
menopause (average age of onset is 51 years) which is 
associated with mental health outcomes. Pregnant 
women, women living overseas, women with a 
psychiatric illness (other than anxiety or depression) or 
an incomplete PCOS diagnosis were excluded from the 
research. 
 Measures: 
 Hospital anxiety and depression scale (HADS) was 
used to assess anxiety and depression.
10
 HADS is a 
reliable instrument to screen for clinically significant 
anxiety and depression in patients attending a general 
medical clinic. It is also a valid measure of the severity 
of these mood disorders. This questionnaire contains 14 
questions, including 7 each for rating anxiety and 
depression. The scale has been found to be equivalent 
to Hamilton anxiety or depressive scales in reliability 
and validity. A score of 0–7 on either subscale is 
regarded as normal, 8–10 as suggestive of presence of 
mild alterations, and that of 11 or higher indicates 
probable presence of the particular mood disorder or 
anxiety disorder.  
RESULT 
Out of 100 Patients , 42% of the patients were on 22-26 
age group followed by 36% were on the 17-21 age 
group (Table no.1) .On  analysis of Body Mass Index , 
60% of the patient having BMI of 18.5 – 25 followed 
by 24% having BMI of 25-30. Distribution of BMI 
according to the age founds that patients in 17-21 age 
group were having high BMI Score (obese) followed 
by patients in 22-26 were having moderately BMI 
(Over weight). The Hospital Anxiety and Depression 
Scale HADS was used to measure of anxiety and 
depression among sample PCOD patient (Table No.2) 
and it indicates  that 52% having  score in between 11-
21 (abnormal)  in which  36%  having anxiety and 16%  
having Depression. 48% of patient having score in 
between   8-11 (Borderline) in which 26% having 
borderline anxiety and 22%  having borderline 
Depression.  
Table 1: Age wise distribution of patients 
Sl No Age 
Groups 
No of 
patients 
Percentage 
1 12  to 16 4 4 % 
2 17 to 21 36 36% 
3 22 to 26 42 42% 
4 27 to 31 16 16% 
5 32 to 36 2 2% 
 
Table 2: Distribution based on haad score 
Sl.No Scoring 0-7 (Normal) 
 
8-11(Borderline) 
 
11-21 (Abnormal) 
1 Anxiety 38(38%) 26(26%) 36(36%) 
2 Depression 62(62%) 22(22%) 16(16%) 
 
DISCUSSION 
 Goal of this study was to assess anxiety and depression 
among PCOS patients. Our study observed high 
prevalence of anxiety disorder in PCOS. Similar 
findings have been observed by earlier researchers.
11,12
 
High anxiety level in PCOS may be due to infertility, 
loss of sexuality, acne, hirsutism, and obesity.
13-15
 
Depression in PCOS may be related to change in 
physical appearance as obesity, acne, and hirsutism 
lead to negative perception of self and social 
withdrawal, which culminates into depression. . Earlier 
studies have also reported similar findings. Rassi et 
al.
16
 observed depression in 26% patients whereas 
Hollinrake et al.
17
 found 21% prevalence of depression 
in PCOS.As this study concludes that there were high 
level of prevelance of anxiety and depression in PCOS 
patients. 
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